COMMON & BRAND NAMES
Anorectic; Potential Hallucinogen
Lorcaserin (Belviq) is a new serotonergic anorectic approved by the FDA as a weight-loss drug in June 2012. According to the FDA, it also has "CNS hallucinogenic properties". It was placed in Schedule IV on May 7, 2013. It is expected to become commercially available in June, 2013.